SenesTech, Inc. (SNES) Analysts See $-0.19 EPS

March 15, 2018 - By Marguerite Chambers

 SenesTech, Inc. (SNES) Analysts See $ 0.19 EPS

Analysts expect SenesTech, Inc. (NASDAQ:SNES) to report $-0.19 EPS on March, 29.After having $-0.28 EPS previously, SenesTech, Inc.’s analysts see -32.14 % EPS growth. The stock increased 4.28% or $0.03 during the last trading session, reaching $0.65. About 79,796 shares traded. SenesTech, Inc. (NASDAQ:SNES) has 0.00% since March 15, 2017 and is . It has underperformed by 16.70% the S&P500.

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company has market cap of $10.26 million. The firm focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It currently has negative earnings. It is also developing a pipeline of fertility control and animal health products, including plant fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

More notable recent SenesTech, Inc. (NASDAQ:SNES) news were published by: which released: “SenesTech, Inc. (SNES) Prices Offering of Common Stock and Warrants” on November 17, 2017, also with their article: “SenesTech, Inc. (SNES) Climbs 100% After Announcing Distribution Agreement …” published on October 23, 2017, published: “Meet Arizona’s newest public company” on December 09, 2016. More interesting news about SenesTech, Inc. (NASDAQ:SNES) were released by: and their article: “SenesTech Inc.” published on December 08, 2016 as well as‘s news article titled: “SenesTech Launches ContraPest® Fertility Control Product “Research Sales”” with publication date: December 14, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.